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Abstract
The various aspects of the automobile industry also carry with it the risk for occupational health hazards with it. Toluene has also evolved as a 
commonly used drug by substance abusers. Accidental exposure or self-poisoning with these substances has been reported in literature. These sub-
stances can also cause distal renal tubular acidosis (RTA), acute tubular necrosis, glomerulonephritis and interstitial nephritis,  rhabdomyolysis 
and myoglobinemia. In this series, we report about three patients who developed renal manifestations because of organic solvents. Two of 
the three patients had ingested the paint reducer substance and the third one was addicted to sniffing the toluene based paint reducer. All the 
patients had in taken these substances s with suicidal intent and developed acute kidney injury (AKI) and severe metabolic acidosis. One of the 
patients had features of rhabdomyolysis as well. The third patient was a substance abuser and had inhaled higher than usual dose and developed 
severe and refractory acidosis and mild kidney injury and required Renal Replacement Therapy (RRT) for acidosis. All the patients eventually 
recovered their kidney functions and were doing well during their follow-up. Toluene based organic solvents lead to acute neurological symp-
toms, accompanied by severe metabolic alterations, organ injury and dysfunction. An association of the development of hypokalemic paralysis 
and metabolic acidosis with toluene intoxication has been observed. The management of acute toluene toxicity is mainly conservative, consisting 
of electrolytes correction, acid-base and fluid abnormalities and renal replacement therapy in severe AKI. Organic solvent exposure may result 
in acute tubular necrosis, rhabdomyolysis, RTA and AKI irrespective of the intake route. Clinical suspicion of organ dysfunction and failure and 
timely induction of supportive care leads to a good outcome.
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Introduction
Organic solvents, commonly used in the automobile indus-
try, have been reported to lead to kidney injury. These 
involve almost any compartment of the kidney i.e. glomer-
ulus, tubules or vasculature. Moreover, these substances 
also aggravate the progression of underlying kidney 
diseases  (1–5). Occupational health hazards are the known 
contributors to morbidity and mortality of workers in the 
industry. The factors contributing to this risk include the 
extent of exposure, ventilation maintenance, access to fluid 
intake, etc. A paint reducer, an organic solvent frequently 
used in the automobile manufacturing and repair industry, 
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myalgias and decreased urine output after having consumed 
around 150 mL of paint reducer. There was no history of 
loss of consciousness, seizures, drug abuse, trauma, vom-
iting, fever or loose stools. His blood pressure was 140/88 
mmHg, with a pulse rate of 110 bpm. His clinical exam-
ination revealed mild tenderness of limbs. Investigations 
revealed normal blood counts: serum creatinine, 5.4 mg/dL; 
serum potassium, 6.2 meq/dL; sodium, 141 meq/dL. Three-
fold elevation of liver enzymes, normal bilirubin, serum 
calcium and phosphorus were normal. Normal anion gap 
metabolic acidosis with serum bicarbonate of 15 meq/dL 
with a positive urine anion gap was observed. The patient’s 
Creatine phsophokinase (CPK) was 1040 U/L, and LDH 
was 560 U/L. Urine for myoglobin was negative. Rhabdo-
myolysis and AKI with RTA were induced by the suspected 
organic solvent. The patient was initiated with intravenous 
normal saline, received three sessions of haemodialysis 
and was given oral bicarbonate 0.5 meq/kg. Over the next 
2 weeks, the patient’s clinical condition improved. At dis-
charge, the lab analysis revealed a serum potassium level of 
3.9 meq/dL, serum bicarbonate of 24.2 meq/dL and creat-
inine of 1.4 mg/dL. The patient was seen by a psychiatrist, 
received behavioural therapy,continues to follow the treat-
ment and is doing well. 
Case 3
A thirty-two-year patient was missing from his home for 
2  days and was found by his parents. The patient was a 
driver by profession and had previously undergone rehabil-
itation 2 years before for drug abuse behaviour. But patient 
had relapsed and had started sniffing toluene-based organic 
solvent. The patient had locked himself  up in his car and 
consumed more than his usual dose and developed altered 
sensorium before being found by his family. On presentation, 
the patient was not oriented and was talking irrelevantly. 
His blood pressure was 110/90 mmHg with a pulse rate of 
134/bpm. The echocardiography showed sinus tachycardia. 
Lab analysis revealed serum creatinine levels of 2.9 mg/dL, 
sodium of 150 meq/dL, potassium of 5.1 meq/dL, normal 
calcium and phosphorus (bland urine sediment). His CPK, 
LDH liver functions were normal. The patient had a urine 
output of 0.6 mL/kg/h and severe metabolic acidosis (nor-
mal anion gap) and received two sessions of haemodialysis, 
intravenous saline, oral bicarbonate replacement and dra-
matically recovered. On day 7 of his hospital stay, all param-
eters had normalised. Hence the patient was discharged and 
attached to a rehabilitation centre.
Discussion
Organic solvents, particularly toluene-based, have become 
a common occupational hazard and a frequent abused 
is one such risk factor. Reducers are volatile solvents consist-
ing of a mixture of organic compounds like aromatic hydro-
carbons, halogenated hydrocarbons and naphtha, toluene, 
xylene, acetone, hexane, benzene and methyl isobutyl ketone 
etc. (6–8). 
Toluene is a common constituent in many industrial sol-
vents and has a known toxicity profile that shows environ-
mental, accidental and intentional poisoning. Toluene finds 
its use in paints, paint reducers, polishing solvents, cleaning 
products, glues, adhesives, etc. (9). It is also a drug that sub-
stance abusers easily lay hands-on as an inhaled substance 
(glue sniffing). It leads to significant acute neurological 
effects such as euphoria followed by depression. The toxic-
ity of toluene has been reported in the literature and impacts 
any organ system (10, 11). It is metabolised via cytochrome 
p-450 into hippuric acid and benzocaine acid and is excreted 
through the urine (11–13). It can also result in rhabdomyoly-
sis, myoglobinemia, distal renal tubular acidosis (RTA) and 
acute tubular necrosis (14–18). The other clinical conditions 
that arise are a fulminant hepatic failure, lung haemorrhage, 
solvent encephalopathy, solvent psychosis, cerebral infarc-
tion, cerebellar dysfunction, cardiac arrhythmias and death 
(19–26). In this series, we report our experience with AKI 
because of toluene-based paint reducers. 
Case Series
Case 1
A 40-year-old male working in an automobile repair work-
shop presented with multiple episodes of vomiting and altered 
sensorium after intentional consumption of around 200 mL 
of toluene-based paint reducer. The patient was poorly 
cooperative. His pulse rate was 124/min, blood pressure was 
130/80 mmHg and oxygen saturation on ambient air was 94%. 
The patient was initiated on intravenous normal saline. The 
blood pressure remained stable, and over the next 4 days, his 
serum creatinine increased from 1.1 mg/dL to 6.3 mg/dL with 
anion gap metabolic acidosis. His haemoglobin was 14 g/dL. 
Serum creatine phosphokinase, lactate dehydrogenase (LDH), 
sodium, potassium, calcium and phosphorus levels were nor-
mal. His Liver functions were normal. Ultrasonography of the 
abdomen and bland sediment in urine was also examined. The 
patient received four sessions of dialysis during the hospital 
stay. On day 10, his urine output improved to 2 L per day with 
no metabolic acidosis, and serum creatinine was 2.1 mg/dL. 
The patient was discharged and was asked to follow up at 4 
weeks. On day 24, his serum creatinine was 1.2 mg/dL and was 
suggested for continuing psychiatry follow-up. 
Case 2
This patient was a 20-year male working in the automo-
bile repair unit who presented with complaints of nausea, 
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substance. These cause acute neurological symptoms, severe 
metabolic abnormalities and associated organ injury. One of 
the predominantly observed side effects of toluene intoxica-
tion is metabolic acidosis. Organic solvents can also result 
in liver injury and rhabdomyolysis. Some risk factors that 
suggest poor outcomes include altered mental status, renal 
failure and severe acidemia. Although our patients had both 
organ impairment and altered mental status, they managed 
to do well (11). 
Toluene causes glomerular and tubular damage, Fanconi 
syndrome and hematuria. Proteinuria is common, although 
it seldom is in the nephrotic-range levels. Occupational 
exposure of toluene in patients with established glomerulo-
nephritis is a known risk factor for progression to end-stage 
renal disease. Direct induction of acute tubular necrosis and 
acute oliguric renal failure are also associated with toluene 
intoxication (5, 15, 16, 27–29). Rhabdomyolysis results either 
because of direct toluene muscular injury or prolonged 
immobility. They are usually seen with ingestion of toluene, 
but is reported in patients with thinner intoxication by inha-
lation (5, 30–32). Moreover, electrolyte abnormalities like 
hypokalemia and hypophosphatemia can also result in rhab-
domyolysis and hence AKI. 
The muscular phosphate depletion from severe hypophos-
phatemia impairs ATP production, which leads to muscle 
injury by altering the oxygen-haemoglobin dissociation 
curve (33, 34). Type 1 distal RTA which is characterized by 
an inability to lower urine pH, despite acidemia results, in 
hyperchloremic metabolic acidosis with hypokalemia. The 
degree of hypokalemia is also an important factor and can 
lead to rhythm abnormality and or hypokalemic paralysis. 
The primary suggested mechanism in toluene-induced type 
1 distal RTA is an inability of the distal tubule to excrete 
hydrogen ions and an increased production of hippuric 
acid by toluene metabolism (16, 35). Management of acute 
toluene-based solvent toxicity is largely conservative, and 
the measures taken are influenced by the severity of organ 
involvement. Broadly it involves correction of the electro-
lytes, acid-base and fluid abnormalities. The management 
focuses on aggressive potassium replacement, maintaining 
hydration and close monitoring of the cardiac rhythm. Large 
doses of bicarbonate and potassium replacement are often 
needed. Patients should be closely observed for the devel-
opment of organ dysfunction. Rhabdomyolysis should be 
ruled out in patients particularly, with impaired renal param-
eters. A timely introduction of renal replacement therapy is 
needed. Mild transaminitis, which is reversible, has been pre-
viously reported in the literature (10, 32).
Conclusion
Organic solvent exposure may result in acute tubular necro-
sis, rhabdomyolysis, RTA and AKI irrespective of the route 
intake. Clinical suspicion of organ dysfunction and fail-
ure and timely induction of supportive care leads to good 
outcomes.
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